Skip to main content
Home
FULL MENU Close Menu
Home
Home

Jim Kling

News

Synthetic drugs pose regulatory, diagnostic challenges

Author:
Jim Kling
Publish date: May 29, 2019

SAN FRANCISCO – Every year brings about 250 novel recreational drugs.

  • Read More

News

For borderline personality disorder, less may be more

Author:
Jim Kling
Publish date: May 28, 2019

SAN FRANCISCO – Stepped-care regimens rather than psychotherapy could expand access to services, Dr. Joel Paris said.

  • Read More

News

Vet accuracy, privacy policies of mental health apps

Author:
Jim Kling
Publish date: May 28, 2019

SAN FRANCISCO – “It’s our responsibility to understand the medications we’re prescribing, so I don’t think this is any different,” Dr. H...

  • Read More

News

Ketamine may help OCD, but much work remains

Author:
Jim Kling
Publish date: May 23, 2019

SAN FRANCISCO – Off-label use is common with ketamine, but there is little supporting evidence.

  • Read More

News

Ketamine may rely on opioid receptors for antidepressive effect

Author:
Jim Kling
Publish date: May 23, 2019

SAN FRANCISCO – In treatment-resistant individuals, preexposure to an opioid receptor antagonist greatly reduced ketamine’s effect.

  • Read More

News

Intranasal esketamine combo tied to symptom improvement

Author:
Jim Kling
Publish date: May 21, 2019

SAN FRANCISCO – Dr. Michael E. Thase discussed possible alterations in esketamine’s treatment regimen.

  • Read More

News

For some MST survivors, VA hospitals can trigger PTSD

Author:
Jim Kling
Publish date: May 20, 2019

SAN FRANCISCO – Veteran survivors of military sexual trauma are often reluctant to report assaults, but some therapies can help.

  • Read More

News

About one-third of anxiety patients relapse after stopping antidepressants

Author:
Jim Kling
Publish date: May 19, 2019

SAN FRANCISCO – Patients who want to discontinue their antidepressants face a therapeutic dilemma.

  • Read More

News

Looking ahead: Gastroenterology devices over the next decade

Author:
Jim Kling
Publish date: April 25, 2019

SAN FRANCISCO – Dr. V. Raman Muthusamy and Dr. Sri Komanduri sum up the promising technology and the hurdles it...

  • Read More

News

Enhanced recovery also enhances unplanned patient contact

Author:
Jim Kling
Publish date: April 16, 2019

TUSCON, ARIZ. – After implementation of an enhanced recovery after surgery program, patients were more likely to have an unscheduled contact with...

  • Read More

News

Telemedicine proving to be an efficient platform for delivering nutritional services

Author:
Ted Bosworth
Jim Kling
Publish date: April 12, 2019

SAN FRANCISCO – Remote nutritional counseling and coordination can improve access to these vital services for patients with gastrointestinal...

  • Read More

News

Evidence for endoscopic GERD treatments approaching critical mass

Author:
Ted Bosworth
Jim Kling
Publish date: April 12, 2019

SAN FRANCISCO – Dr. Michael Vaezi characterized himself as “cautiously optimistic” that many endoscopic interventions will be included among...

  • Read More

News

The promise of endoscopy simulation–based training and gaps as targets for innovation

Author:
Ted Bosworth
Jim Kling
Publish date: April 12, 2019

SAN FRANCISCO – “Currently, there is a lack of evidence that simulation adoption by practicing endoscopists leads to better patient outcomes.”

  • Read More

News

AI boosts gastroendoscopy, supports clinicians

Author:
Jim Kling
Publish date: April 12, 2019

SAN FRANCISCO – Current efforts focus on video recording and physician support, but optical biopsies are not here...

  • Read More

News

Dolutegravir passes late pregnancy test

Author:
Jim Kling
Publish date: April 12, 2019

SEATTLE - In ART-naive women in the third trimester of pregnancy, dolutegravir led to reduced viral load at delivery compared to efavirenz.

  • Read More

Pages

  • « first
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close